ATP13A2 and Parkinson disease: In idiopathic PD and Dementia with Lewy Bodies, ATP13A2 protein levels are significantly decreased postmortem, suggesting that altered ATP13A2 function may be more pervasive in phenotypic PD than previously considered [8].